Clinical Outcomes Among Patients With Drug-resistant Tuberculosis Receiving Bedaquiline- or Delamanid-Containing Regimens

BACKGROUND: Bedaquiline and delamanid are newly available drugs for treating multidrug-resistant tuberculosis (MDR-TB); however, there are limited data guiding their use and no comparison studies. METHODS: We conducted a prospective, observational study among patients with MDR-TB in Georgia who were...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Clin Infect Dis
Egile Nagusiak: Kempker, R R, Mikiashvili, L, Zhao, Y, Benkeser, D, Barbakadze, K, Bablishvili, N, Avaliani, Z, Peloquin, C A, Blumberg, H M, Kipiani, M
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2019
Gaiak:
Major Articles and Commentaries
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7713674/
https://ncbi.nlm.nih.gov/pubmed/31712809
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciz1107
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak